News | September 10, 2008

Preclinical Imaging Seen from ‘New Point of View’

September 11, 2008 - For the fifth year, Siemens Healthcare ( presented the “New Point of View” Preclinical Image of the Year Awards, designed to demonstrate how Siemens preclinical imaging systems help researchers improve the quality of imaging and overall research, at the Siemens Preclinical User’s Group Meeting, held in Nice, France.

The awards are intended to honor pioneering researchers and their contributions. Advanced new imaging solutions and multimodal systems are shedding new light on dissecting disease processes and unlocking potential new treatments. Images were acquired on Siemens preclinical imaging systems: the Inveon preclinical scanner and the microPET (positron emission tomography) and microCAT (computed axial tomography) scanners, which have been long-time industry leaders.

“The ‘New Point of View’ image competition illustrates the breadth and novelty of applications for which preclinical imaging technologies are being used. The potential for breakthrough discoveries will eventually have impact in the clinical environment through translational research,” said Kirti Patel, vice president, Preclinical Solutions, Siemens Healthcare. “Our focus is to provide high-quality preclinical imaging tools and workflow solutions that will speed the discovery process for our customers.”

The “New Point of View” competition was open to anyone with a Siemens preclinical scanner. Researchers were allowed to use any type of radiopharmaceutical tracer or any other contrast material. Entries were judged on scientific merit, the type of information gleaned from the images and the overall quality of the images. All images were judged by a panel of industry experts and members of Siemens Preclinical Research and Development team.

Inveon Image of the Year Winner
“4-Dimensional Dosimetry of 131I-NM404 Using µPET/CT and Pinnacle,” acquired by J. Grudzinski, M. Christensen, W. Tome, M. Bahl and J. Weichert, University of Wisconsin.

Multimodality Image of the Year Winner
“Quantification of PECAM-1 Expression in Regions of Myocardial Infarction Using MR-PET,” acquired by L. Locke, Z. Yang, Y. Zhang, R. Tian, B. Kundu, J. Linden, S. Berr and D. Pan, University of Virginia.

Most Innovative Image of the Year Winner
“Kit-like” labeling of PET tracers: 18F-SiFA for bloodpool imaging of transplanted rat hearts,” acquired by G. Boening, University of Munich.

Drug Discovery Image of the Year Winner
“P-glycoprotein modulation at the rat blood-brain barrier studied with (R)-[11C]-Verapamil PET,” acquired by C. Kuntner, J. Bankstahl, A. Abrahim, R. Karch, J. Stanek, T. Wanek, M. Zsebedics, W. Wadsak, K. Kletter, M. Müller, W. Löscher, O. Langer, Austrian Research Centers GmbH-ARC.

For more information:

Related Content

PET Tracer Gauges Effectiveness of Promising Alzheimer's Treatment

Longitudinal PET imaging with 18F-AV45. PET imaging shows the average 18F-AV45 uptake per animal group at 8 and 13 months of age. A significant interaction of genotype treatment was observed in the cortex (p = 0.0248), hippocampus (p = 0.0071) and thalamus (p = 0.0084), indicating reduced [18F]-AV45 uptake in BACE1 inhibited transgenic mice. Credit: MICA, University of Antwerp, Belgium.

News | Radiopharmaceuticals and Tracers | December 28, 2017
In the December featured basic science article in The Journal of Nuclear Medicine, Belgian researchers report on the...
Michael J. Fox Foundation and Tau Consortium Developing PET Tracers for Neurodegenerative Disease
News | Radiopharmaceuticals and Tracers | October 27, 2017
The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Tau Consortium announced a funding partnership to...
Videos | Nuclear Imaging | August 24, 2017
Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and p
Study Demonstrates First Human Application of Novel PET Tracer for Prostate Cancer

Transaxial 11Csarcosine hybrid PET/CT showed a (triangulated) adenocarcinoma in the transition zone of the anterior right prostate gland on PET (A), CT (B), and a separately obtained T2?weighted MR sequence (C) with resulting PET/MRI registration (D). Image courtesy of M. Piert et al., University of Michigan, Ann Arbor, Mich.

News | Radiopharmaceuticals and Tracers | August 16, 2017
In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the...
Novel PET Tracer Detects Small Blood Clots

PET images (MIP 0-60 min) of three Cynomolgus monkeys. Strong signals are detected at the sites where inserted catheters had roughened surfaces. Almost no other background signal is visible. Only accumulation in the gallbladder becomes visible at the bottom of the image. Credit: Piramal Imaging GmbH, Berlin Germany.

News | PET Imaging | July 07, 2017
July 7, 2017 — Blood clots in veins a

While subject No. 1 (left) was judged as positive for both the neuronal injury and the amyloid load biomarker, both Alzheimer's disease biomarkers were negative in subject No. 2 (right). Image courtesy of Henryk Barthel et al., University Hospital Leipzig, Leipzig, Germany

News | PET Imaging | June 14, 2017
More people die of Alzheimer's disease than prostate and breast cancer combined. Identifying the disease before major...
News | Clinical Study | June 09, 2017
The milestone Imaging Dementia — Evidence for Amyloid Scanning (IDEAS) Study is working with government and academic...
Lantheus and GE Healthcare Sign Agreement for Worldwide Development, Commercialization of Flurpiridaz F-18
News | Radiopharmaceuticals and Tracers | May 22, 2017
May 22, 2017 — Lantheus Holdings Inc., parent company of Lantheus Medical Imaging Inc., and GE Healthcare announced t
low-dose lung CT scan

An example of a low-dose CT scan of the lungs, showing lung cancer. Image courtesy of Toshiba.

Feature | Lung Cancer | May 05, 2017 | Alison Grimes
The term mesothelioma was coined in 1909, just a few years after the introduction of medical X-ray imaging.
Australian Team Finds New Method for Producing PET Radiotracers in Higher Radiochemical Yields
News | Radiopharmaceuticals and Tracers | April 28, 2017
April 28, 2017 — Researchers at the Australian Nuclear Science and Technology Organisation (ANSTO) have led the devel
Overlay Init